Clinitech Laboratory Ltd vs Nidan Laboratories Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 30 as of 30 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 .The P/E Ratio of Nidan Laboratories & Healthcare Ltd is 0 as of March 2025 . The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 .The Market Cap of Nidan Laboratories & Healthcare Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Nidan Laboratories & Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About Nidan Laboratories & Healthcare Ltd

Nidan Laboratories & Healthcare Limited was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 with the Registrar of Companies, Maharashtra.
Subsequently, the name of the Company was changed from 'Abhi Diagnostic Imagings Private Limited' to 'Nidan Laboratories And Healthcare Private Limited' and fresh Certificate of Incorporation dated March 24, 2021 was issued by the Registrar of Companies.
The status of the Company was converted into a Public Limited Company and the name was changed to Nidan Laboratories & Healthcare Limited' on May 24, 2021.
At present, Company carry on the business of providing various Healthcare & Diagnostics Service Centres, such as X-Ray, Sonography, 2 D ECHO, PFT, CST, C.T. Scan, MRI, Blood Bank, Pathology Laboratories, Dialysis Unit, Intensive Care Unit, Burn & Poisoning Centre and Poly Clinic.

FAQs for the comparison of Clinitech Laboratory Ltd and Nidan Laboratories & Healthcare Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Nidan Laboratories & Healthcare Ltd?

Market cap of Clinitech Laboratory Ltd is 6 Cr while Market cap of Nidan Laboratories & Healthcare Ltd is 18 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Nidan Laboratories & Healthcare Ltd?

The stock performance of Clinitech Laboratory Ltd and Nidan Laboratories & Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Nidan Laboratories & Healthcare Ltd?

As of October 31, 2026, the Clinitech Laboratory Ltd stock price is INR ₹30.0. On the other hand, Nidan Laboratories & Healthcare Ltd stock price is INR ₹13.0.

How do dividend payouts of Clinitech Laboratory Ltd and Nidan Laboratories & Healthcare Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Nidan Laboratories & Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.